You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HNSCC

Showing 1 - 25 of 735
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,

Not yet recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 18, 2023

HNSCC Trial (Danvatirsen, Pembrolizumab)

Not yet recruiting
  • HNSCC
  • (no location specified)
Apr 3, 2023

Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)

Not yet recruiting
  • Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
  • Monalizumab
  • Cetuximab
  • (no location specified)
Jan 8, 2023

Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
  • Black Raspberry
  • (no location specified)
Oct 16, 2023

Head Neck Cancer Trial in Beijin (anti-PD-1 or PD-L1 antibody, postoperative radiaotherapy)

Recruiting
  • Head and Neck Cancer
  • anti-PD-1 or PD-L1 antibody
  • postoperative radiaotherapy
  • Beijin, Beijing, China
    National Cancer Center /National Clinical Research Center for Ca
Mar 18, 2023

Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)

Not yet recruiting
  • Head and Neck Cancer
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Oct 18, 2023

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, Pembrolizumab Trial in Beijing (Pembrolizumab, Cisplatin,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Beijing, Beijing, China
    Beijing Tongren Hospital
Oct 26, 2023

Head Neck Cancer Trial in Tampa (Prolonged Nightly Fasting, Regular Eating pattern)

Recruiting
  • Head and Neck Cancer
  • Prolonged Nightly Fasting
  • Regular Eating pattern
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Head and Neck Squamous Cell Carcinoma Trial in Candiolo (inulin, Pembrolizumab, Nivolumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • inulin
  • +2 more
  • Candiolo, Turin, Italy
    Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
Apr 7, 2023

HNSCC Trial in Aurora (Alpha Lipoic Acid)

Recruiting
  • HNSCC
  • Alpha Lipoic Acid
  • Aurora, Colorado
    Abigail E Berry
May 12, 2022

HNSCC, Radiotherapy, PD-1 Trial in Guangzhou (PD-1inhibitor, concurrent chemoradiotherapy)

Recruiting
  • HNSCC
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen memorial hospital
Aug 6, 2023

Head and Neck Squamous Cell Carcinoma, HNSCC, Squamous Cell Carcinoma of the Larynx Trial (Cemiplimab-Rwlc)

Withdrawn
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • (no location specified)
Aug 1, 2022

HNSCC, Oral Cancer, PD-1 Trial in Guangzhou (Perbolizumab+Carboplatin+albumin-bound paclitaxel:4 courses,

Recruiting
  • HNSCC
  • +2 more
  • Perbolizumab+Carboplatin+albumin-bound paclitaxel:4 courses
  • Perbolizumab+Carboplatin+albumin-bound paclitaxel:2 courses
  • Guangzhou, Guangdong, China
    Sun yat-sen memorial hospital
Aug 6, 2023

Epigenetic Silencing of MicroRNA for Predicting Therapeutic

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Not interventional
  • Albuquerque, New Mexico
    University of New Mexico - Cancer Center
Oct 4, 2022

Human Papillomavirus (HPV), Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in New York (radiation, other, drug)

Withdrawn
  • Human Papillomavirus (HPV)
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • RT 50 Gy
  • +6 more
  • New York, New York
    Mount Sinai Hospital
Jul 1, 2022

HNSCC Trial in Tucson (Abemaciclib)

Recruiting
  • HNSCC
  • Tucson, Arizona
    University of Arizona
Mar 3, 2022

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023

HNSCC Trial in Cincinnati, Cleveland, Philadelphia (Cesium-131, Pembrolizumab)

Recruiting
  • HNSCC
  • Cincinnati, Ohio
  • +2 more
Oct 4, 2022

Head and Neck Squamous Cell Carcinoma Trial in Brescia (Niraparib)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Brescia, Italy
    Asst Degli Spedali Civili Di Brescia
Aug 3, 2022

Prognostic Immune Biomarkers in HNSCC

Completed
  • Head and Neck Cancer
  • Squamous Cell Carcinoma
  • Tumour immunoprofile evaluation
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Jul 3, 2023

Squamous Cell Carcinoma, Head Neck Cancer Trial in Tampa (Intensity-modulated radiotherapy, Magnetic Resonance Guidance)

Recruiting
  • Squamous Cell Carcinoma
  • Head and Neck Cancer
  • Intensity-modulated radiotherapy
  • Magnetic Resonance Guidance
  • Tampa, Florida
    Moffitt Cancer Center
Nov 13, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Chapel Hill, Charleston (biological, drug, radiation)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Pembrolizumab
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 25, 2022

Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Dec 20, 2022

Therapy Using 18F-FSPG PET

Not yet recruiting
  • Cancer
  • +3 more
  • 18F-FSPG PET/CT in NSCLC
  • 18F-FSPG PET/CT in HNSCC
  • (no location specified)
May 24, 2023

Head and Neck Squamous Cell Cancer Trial in London (BYL719)

Active, not recruiting
  • Head and Neck Squamous Cell Cancer
  • London, Ontario, Canada
    London Health Sciences Centre, London Regional Cancer Program
Jun 14, 2022